Armata Pharmaceuticals, Inc. Income Statement

Income Statement Dec2013 Dec2014 Dec2015 Dec2016 Dec2017 Dec2018 Dec2019 Dec2020 Dec2021 Dec2022 Dec2023 Dec2024
Revenue & cost
Revenue 0.08M0.41M0.47M0.26M0.12M-1.01M-0.93M0.20M4.37M5.51M1.90M-5.57M
Gross Profit 0.08M0.41M0.47M0.26M0.12M-1.01M-0.93M0.20M4.37M5.51M1.90M-5.57M
Operating items
Amortization - Intangibles 2.64M
Research & Development 6.47M5.80M3.99M5.68M2.88M8.37M9.82M14.44M20.02M35.02M33.77M34.43M
Selling, General & Administrative 6.00M6.85M6.71M8.41M7.59M2.52M9.27M7.97M8.28M7.44M11.65M13.18M
Restructuring Costs 9.17M8.25M
Other Operating Expenses 1.86M9.55M5.80M-27.82M-21.34M-9.17M-8.25M
Operating Expenses 12.46M14.52M10.70M23.64M16.27M17.66M19.75M22.41M28.30M42.45M45.42M47.61M
Operating Income -12.38M-14.11M-10.23M-23.38M-16.16M-17.66M-19.75M-21.59M-23.82M-36.95M-40.89M-42.44M
EBIT -12.38M-14.11M-10.23M-23.38M-16.16M-17.66M-19.75M-21.59M-23.82M-36.95M-40.89M-42.44M
Non-operating items
Interest & Investment Income 0.24M0.10M0.03M0.01M0.03M0.18M
Other Non Operating Income -52.20M37.22M9.94M4.54M2.02M1.72M1.12M-0.59M0.67M0.03M-28.16M31.40M
Non Operating Income -52.20M37.22M9.64M3.98M2.02M0.96M0.27M-0.59M0.67M0.03M-28.16M23.52M
Net income details
EBT -12.62M23.11M-2.41M-19.39M-14.14M-16.70M-19.48M-22.19M-23.92M-36.92M-43.34M-53.18M
Tax Provisions -0.07M-0.56M-1.30M-0.33M
Profit After Tax -64.58M23.11M-0.52M-18.84M-12.84M-16.70M-19.48M-22.18M-23.16M-36.92M-69.05M-18.92M
Income from Continuing Operations -12.62M23.11M-2.33M-18.84M-12.84M-16.37M-19.48M-22.19M-23.92M-36.92M-43.34M-53.18M
Consolidated Net Income -12.62M23.11M-2.33M-18.84M-12.84M-16.37M-19.48M-22.19M-23.92M-36.92M-43.34M-53.18M
Income towards Parent Company -12.62M23.11M-2.33M-18.84M-12.84M-16.37M-19.48M-22.19M-23.92M-36.92M-43.34M-53.18M
Preferred Dividend Payments 0.62M1.28M10.28M1.86M
Net Income towards Common Stockholders -65.20M15.76M-10.79M-24.28M-14.36M-16.70M-20.42M-22.18M-23.92M-36.92M-43.34M-53.18M
Additional items
EPS (Basic) -0.00M0.00M-0.00M-0.00M-0.00M-0.00M-0.00M-0.00M-0.00M-0.00M-0.00M-0.00M
EPS (Weighted Average and Diluted) -0.00M-0.00M-0.00M-0.00M-0.00M-0.00M-0.00M-0.00M-0.00M-0.00M-0.00M-0.00M
Shares Outstanding (Weighted Average) 0.03M0.04M0.04M0.08M0.68M2.31M9.93M18.70M27.09M36.14M36.15M36.18M
Shares Outstanding (Diluted Average) 101.20M5.89M5.41M0.98M6.57M
EBITDA -57.61M-14.11M-10.23M-23.38M-16.16M-16.70M-19.48M-21.59M-23.82M-36.95M-40.89M-42.44M
Tax Rate 3.03%2.87%9.21%1.96%